Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00459)
| DIG Name |
Lactitol monohydrate
|
||||
|---|---|---|---|---|---|
| Synonyms |
Lactitol monohydrate; 81025-04-9; D-Lactitol monohydrate; Lactitol (monohydrate); UNII-UH2K6W1Y64; 4-O-beta-D-Galactopyranosyl-D-glucitol monohydrate; UH2K6W1Y64; MFCD00150767; (2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol;hydrate; SMR000499577; Lactitol hydrate; Portolac (TN); C12H26O12; Lactitol hydrate (JAN); DSSTox_CID_27028; DSSTox_RID_82049; DSSTox_GSID_47028; MLS001076675; MLS001361361; MLS002207095; SCHEMBL230581; D-Glucitol, 4-O-beta-D-galactopyranosyl-, monohydrate; D-Lactitol monohydrate, ~99%; CHEMBL1200429; DTXSID6047028; HMS2231O06; HY-B1389; Tox21_302283; 2588AC; s5282; CCG-268187; CS-4859; NCGC00256064-01; AS-57306; CAS-81025-04-9; D02039; Q27291076; Lactitol, United States Pharmacopeia (USP) Reference Standard; Lactitol monohydrate, European Pharmacopoeia (EP) Reference Standard; (2S,3R,4R,5R)-4-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)hexane-1,2,3,5,6-pentaol hydrate; (2S,3R,4R,5R)-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexane-1,2,3,5,6-pentol hydrate
|
||||
| DIG Function |
Diluent; Flavoring agent
|
||||
| Formula |
C12H26O12
|
||||
| Canonical SMILES |
C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O.O
|
||||
| InChI |
1S/C12H24O11.H2O/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12;/h4-21H,1-3H2;1H2/t4-,5+,6+,7+,8-,9-,10+,11+,12-;/m0./s1
|
||||
| InChIKey |
LXMBXZRLTPSWCR-XBLONOLSSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 362.33 | Topological Polar Surface Area | 202 | |
| XlogP | N.A. | Complexity | 343 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 8 | ||
| Hydrogen Bond Donor Count | 10 | Hydrogen Bond Acceptor Count | 12 | ||